查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1936967

全球豬疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Swine Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 227 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計豬疫苗市場規模將從 2025 年的 22.8 億美元成長到 2034 年的 36.9 億美元，2026 年至 2034 年的複合年成長率預計為 5.49%。

受豬群感染疾病日益普遍的推動，豬隻疫苗市場預計將呈現強勁成長。隨著全球豬肉需求持續攀升，確保豬群健康和生產力的有效疫苗接種策略至關重要。新病原體的出現和先前已控制的疾病的復發，都要求疫苗製劑的研發必須持續進行。各公司正大力投資於創新技術，例如重組疫苗和mRNA疫苗，這些技術有望提高疫苗的有效性和安全性，從而應對養豬戶面臨的不斷變化的挑戰。

此外，畜牧養殖戶生物安全意識的提高對豬隻疫苗市場產生了顯著影響。養殖戶越來越認知到疫苗接種作為綜合畜群管理策略的關鍵要素的重要性。這種意識的轉變推動了疾病預防工作的積極發展，從而提高了疫苗接種率，並建構了更具抵抗力的豬群。將數位化工具應用於疫苗接種計劃的監測和管理也日益普及，使養殖戶能夠最佳化畜群健康管理實踐，並提高整體生產力。

此外，全球養豬業的擴張，尤其是在新興市場，為豬隻疫苗市場帶來了盈利機會。隨著各國不斷提升畜牧能力以滿足日益成長的消費需求，實施先進的疫苗接種計畫至關重要。疫苗生產商與農業組織之間的合作有望促進技術轉讓，並改善這些地區取得疫苗技術的途徑。豬疫苗市場前景廣闊，其特點是技術持續創新、疾病防治意識提升以及為改善動物健康和福利所做的努力。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球豬疫苗市場：依產品分類

  • 市場分析、洞察與預測
  • 去活化疫苗
  • 減毒活病毒疫苗
  • 重組疫苗
  • 次單位疫苗
  • 類毒素疫苗
  • 其他產品

第5章：全球豬疫苗市場：依疾病類型分類

  • 市場分析、洞察與預測
  • 豬繁殖與呼吸綜合症（PRRS）
  • 豬環狀病毒2型（PCV2）
  • 黴漿菌肺炎支原體
  • 經典型豬瘟（CSF）
  • 豬流感
  • 丹毒
  • 口蹄疫
  • 非洲豬瘟（ASF）
  • 豬細小病毒
  • 其他疾病類型

第6章：全球豬疫苗市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 獸醫醫院和診所
  • 養豬場
  • 研究機構

第7章 全球豬疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Biogenesis Bago
    • Bioveta
    • Boehringer Ingelheim International GmbH
    • Ceva SantAfA（C）Animale
    • Elanco Animal Health Incorporated
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc
    • Phibro Animal Health Corporation
    • Vaxxinova
    • Virbac
    • Zoetis Inc
簡介目錄
Product Code: VMR11214069

The Swine Vaccines Market size is expected to reach USD 3.69 Billion in 2034 from USD 2.28 Billion (2025) growing at a CAGR of 5.49% during 2026-2034.

The swine vaccines market is set for robust growth, driven by the increasing prevalence of infectious diseases affecting pig populations. As the global demand for pork continues to rise, the need for effective vaccination strategies to ensure herd health and productivity becomes paramount. The emergence of novel pathogens and the resurgence of previously controlled diseases necessitate ongoing research and development in vaccine formulations. Companies are investing heavily in innovative technologies, such as recombinant vaccines and mRNA-based solutions, which promise enhanced efficacy and safety profiles, thereby addressing the evolving challenges faced by swine producers.

Moreover, the growing awareness of biosecurity measures among livestock farmers is significantly influencing the swine vaccines market. Producers are increasingly recognizing the importance of vaccination as a critical component of comprehensive herd management strategies. This shift in mindset is fostering a proactive approach to disease prevention, leading to higher vaccination rates and, consequently, a more resilient swine population. The integration of digital tools for monitoring and managing vaccination schedules is also gaining traction, enabling farmers to optimize their herd health management practices and improve overall productivity.

Additionally, the expansion of the global swine industry, particularly in emerging markets, presents lucrative opportunities for the swine vaccines market. As countries strive to enhance their livestock production capabilities to meet growing consumer demand, the adoption of advanced vaccination programs becomes essential. Collaborations between vaccine manufacturers and agricultural organizations are expected to facilitate knowledge transfer and improve access to vaccination technologies in these regions. The future of the swine vaccines market appears promising, characterized by continuous innovation, increased awareness of disease management, and a commitment to enhancing animal health and welfare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Inactivated vaccines
  • Live attenuated vaccines
  • Recombinant vaccines
  • Subunit vaccines
  • Toxoid vaccines
  • Other products

By Disease Type

  • Porcine reproductive and respiratory syndrome (PRRS)
  • Porcine circovirus type 2 (PCV2)
  • Mycoplasma hyopneumoniae
  • Classical swine fever (CSF)
  • Swine influenza
  • Erysipelas
  • Foot-and-Mouth disease (FMD)
  • African swine fever (ASF)
  • Porcine parvovirus
  • Other disease types

By End-user

  • Veterinary hospitals & clinics
  • Swine farms
  • Research institutes

COMPANIES PROFILED

  • Biogenesis Bago, Bioveta, Boehringer Ingelheim International GmbH, Ceva Sant Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck Co Inc, Phibro Animal Health Corporation, Vaxxinova, Virbac, Zoetis Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SWINE VACCINES MARKET: BY PRODUCT 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Inactivated vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Live attenuated vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. Recombinant vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.5. Subunit vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.6. Toxoid vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.7. Other products Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL SWINE VACCINES MARKET: BY DISEASE TYPE 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Disease Type
  • 5.2. Porcine reproductive and respiratory syndrome (PRRS) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Porcine circovirus type 2 (PCV2) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.4. Mycoplasma hyopneumoniae Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.5. Classical swine fever (CSF) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.6. Swine influenza Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.7. Erysipelas Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.8. Foot-and-Mouth disease (FMD) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.9. African swine fever (ASF) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.10. Porcine parvovirus Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.11. Other disease types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL SWINE VACCINES MARKET: BY END-USER 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Veterinary hospitals & clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Swine farms Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Research institutes Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL SWINE VACCINES MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.2.1 By Product
    • 7.2.2 By Disease Type
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.3.1 By Product
    • 7.3.2 By Disease Type
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.4.1 By Product
    • 7.4.2 By Disease Type
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.5.1 By Product
    • 7.5.2 By Disease Type
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.6.1 By Product
    • 7.6.2 By Disease Type
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SWINE VACCINES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Biogenesis Bago
    • 9.2.2 Bioveta
    • 9.2.3 Boehringer Ingelheim International GmbH
    • 9.2.4 Ceva SantAfA(C) Animale
    • 9.2.5 Elanco Animal Health Incorporated
    • 9.2.6 HIPRA
    • 9.2.7 Indian Immunologicals Limited
    • 9.2.8 Merck & Co. Inc
    • 9.2.9 Phibro Animal Health Corporation
    • 9.2.10 Vaxxinova
    • 9.2.11 Virbac
    • 9.2.12 Zoetis Inc